NSE filing, NSE: ACTIVEINFR. Summary written from the filing by ALFA Finder's alert engine.
Active Infrastructures Ltd: key numbers
- Share price
- ₹172.50
- Market cap
- ₹259.0 Cr
- Revenue (annual)
- ₹96.57 Cr
- Net profit (annual)
- ₹10.23 Cr
- P/E (TTM)
- 25.3×Sector 31.3×
- Promoter holding
- 74.86%+1.55% QoQ
- FII holding
- 2.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Active Infrastructures Ltd
All →Active Infrastructures Management Change
Active Infrastructures Limited has re-appointed Mr. Shreyas Sunil Raisoni as a Non-Executive Non-Independent Director for a term of 12 months, effective September 4, 2026.
Active Infrastructures Annual General Meeting
Active Infrastructures Limited held its 19th Annual General Meeting on September 04, 2026. Shareholders approved financial statements, director re-appointment, and a final dividend.
Active Infrastructures Annual Report
Active Infrastructures Limited issued a corrigendum to its FY 2025-26 Annual Report, incorporating a missing subsidiary secretarial audit report and updated tax deduction instructions.
Active Infrastructures Business Update
Active Infrastructures Limited's step-down subsidiary, Raghukul Shradha Realty LLP, acquired immovable property in Nagpur for a total consideration of ₹35.71 Crore for real estate development.
- Value
- ₹35.71 Cr
Active Infrastructures Annual General Meeting
Active Infrastructures Limited announced its Annual General Meeting scheduled for September 4, 2026. The agenda includes financial statements, final dividend, director reappointment, and related party transactions.
- Value
- ₹10.00 Cr
Active Infrastructures Financial Results
Active Infrastructures Ltd announced Q1 financial results and approved related party transactions up to ₹10 Crore. The board also fixed the record date for final dividend.
- Value
- ₹10.00 Cr
- Execution
- 3 years
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.